Literature DB >> 10066826

Identification of determinants in E2 ubiquitin-conjugating enzymes required for hect E3 ubiquitin-protein ligase interaction.

U Nuber1, M Scheffner.   

Abstract

Members of the hect domain protein family are characterized by sequence similarity of their C-terminal regions to the C terminus of E6-AP, an E3 ubiquitin-protein ligase. An essential intermediate step in E6-AP-dependent ubiquitination is the formation of a thioester complex between E6-AP and ubiquitin in the presence of distinct E2 ubiquitin-conjugating enzymes including human UbcH5, a member of the UBC4/UBC5 subfamily of E2s. Similarly, several hect domain proteins, including Saccharomyces cerevisiae RSP5, form ubiquitin thioester complexes, indicating that hect domain proteins in general have E3 activity. We show here, by the use of chimeric E2s generated between UbcH5 and other E2s, that a region of UbcH5 encompassing the catalytic site cysteine residue is critical for its ability to interact with E6-AP and RSP5. Of particular importance is a phenylalanine residue at position 62 of UbcH5 that is conserved among the members of the UBC4/UBC5 subfamily but is not present in any of the other known E2s, whereas the N-terminal 60 amino acids do not contribute significantly to the specificity of these interactions. The conservation of this phenylalanine residue throughout evolution underlines the importance of the ability to interact with hect domain proteins for the cellular function of UBC4/UBC5 subfamily members.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10066826     DOI: 10.1074/jbc.274.11.7576

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  The ubiquitin-proteasome pathway and proteasome inhibitors.

Authors:  J Myung; K B Kim; C M Crews
Journal:  Med Res Rev       Date:  2001-07       Impact factor: 12.944

2.  Crystal structures of two bacterial HECT-like E3 ligases in complex with a human E2 reveal atomic details of pathogen-host interactions.

Authors:  David Yin-wei Lin; Jianbo Diao; Jue Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

3.  Engineering a protein-protein interface using a computationally designed library.

Authors:  Gurkan Guntas; Carrie Purbeck; Brian Kuhlman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

4.  Sequence determinants of E2-E6AP binding affinity and specificity.

Authors:  Ziad M Eletr; Brian Kuhlman
Journal:  J Mol Biol       Date:  2007-03-19       Impact factor: 5.469

5.  Polyubiquitination by HECT E3s and the determinants of chain type specificity.

Authors:  Hyung Cheol Kim; Jon M Huibregtse
Journal:  Mol Cell Biol       Date:  2009-04-13       Impact factor: 4.272

Review 6.  Structural insights into the catalysis and regulation of E3 ubiquitin ligases.

Authors:  Lori Buetow; Danny T Huang
Journal:  Nat Rev Mol Cell Biol       Date:  2016-08-03       Impact factor: 94.444

7.  Stepwise multipolyubiquitination of p53 by the E6AP-E6 ubiquitin ligase complex.

Authors:  Yuji Masuda; Yasushi Saeki; Naoko Arai; Hidehiko Kawai; Iwao Kukimoto; Keiji Tanaka; Chikahide Masutani
Journal:  J Biol Chem       Date:  2019-09-06       Impact factor: 5.157

8.  The essential Ubc4/Ubc5 function in yeast is HECT E3-dependent, and RING E3-dependent pathways require only monoubiquitin transfer by Ubc4.

Authors:  Kate E Stoll; Peter S Brzovic; Trisha N Davis; Rachel E Klevit
Journal:  J Biol Chem       Date:  2011-02-25       Impact factor: 5.157

9.  Role of ubiquitin and the HPV E6 oncoprotein in E6AP-mediated ubiquitination.

Authors:  Franziska Mortensen; Daniel Schneider; Tanja Barbic; Anna Sladewska-Marquardt; Simone Kühnle; Andreas Marx; Martin Scheffner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

10.  Participation of the ubiquitin-conjugating enzyme UBE2E3 in Nedd4-2-dependent regulation of the epithelial Na+ channel.

Authors:  Christophe Debonneville; Olivier Staub
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.